A new personal genome test is free, but only if you bare all about your life
A startup company says it will give people free genome reports if they’re willing to answer detailed questions about their health, drinking habits, and more, according to Xconomy.
The deal: Nebula Genomics plans to create rough-and-ready maps of people’s genomes, similar to tests from companies like 23andMe. It costs $99 if you want to pay up front, but you can also earn credits toward a free test if you answer some detailed questions about yourself.
The catch: The company wants to sell information about you to drug companies. Cofounder Kamal Obbad says that will only happen if you give permission. You can pick and choose what studies to participate in, he says.
The big picture: By amassing huge troves of health and DNA data on hundreds of thousands of people, scientists are trying to zero in on the genetic predictors of disease. By giving away a DNA test, Nebula is hoping to quickly get into the game too.
“We are figuring out the business model,” Obbad says. “But we’re making a bet that genetics is going to take off.”
What you learn: Nebula will create a picture of your genome that’s quite broad but relatively low in accuracy, known as a “1x genome.” That means each of the billions of DNA letters is read out just once on average (whereas more accurate “30x” sequencing can remove errors).
It’s therefore not a health test, Obbad says: “If you want health or medical information, this is not the solution for you.”
Instead, the company will tell users about their ancestry and various traits linked to athletic performance, height, and eye and hair color, as do companies like 23andMe and Ancestry.com.
Personality traits: Obbad says Nebula will also report on what your DNA says about personality traits such as happiness or risk-taking tendencies. It even claims to be able to make predictions about educational attainment. The meaning of such personality reports or IQ predictions remain controversial, to say the least.
Deep Dive
Biotechnology
Sam Altman invested $180 million into a company trying to delay death
Can anti-aging breakthroughs add 10 healthy years to the human life span? The CEO of OpenAI is paying to find out.
Forget designer babies. Here’s how CRISPR is really changing lives
The gene-editing tool is being tested in people, and the first treatment could be approved this year.
Neuroscientists listened in on people’s brains for a week. They found order and chaos.
The study shows that our brains exist between chaos and stability—a finding that could be used to help tweak them either way.
More than 200 people have been treated with experimental CRISPR therapies
But at a global genome-editing summit, exciting trial results were tempered by safety and ethical concerns.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.